Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D FROHLICH

Showing results (171-180 of 361) with videos related to

Pageof 37
Sort By:
American Journal of Nephrology|March 20, 2004
Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR modelXiaoyan Zhou, Hidehiko Ono, Yuko Ono, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|March 23, 2004
Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertensionDinko Susic, Jasmina Varagic, Jwari Ahn, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHRE Nunez, K Hosoya, D Susic, et al.
Hypertension (Dallas, Tex. : 1979)|August 1, 1996
Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAsD Susic, E Nuñez, E D Frohlich, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2003
Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamicsJasmina Varagic, Dinko Susic, Michel Slama, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1975
Hemodynamic effects of mebutamate in spontaneously hypertensive ratsJ M Pfeffer, M A Pfeffer, E D Frohlich
The American Journal of Cardiology|October 31, 1975
Systolic hypertension: nonhomogeneous diseasesP N Adamopoulos, S G Chrysanthakopoulis, E D Frohlich
Archives of Internal Medicine|July 1, 1984
Review of the overall experience of captopril in hypertensionE D Frohlich, R A Cooper, E J Lewis
Journal of Cardiovascular Pharmacology|January 1, 1985
Arterial compliance in essential hypertensionF H Messerli, E D Frohlich, H O Ventura
The American Journal of Physiology|May 1, 1987
Atrial natriuretic peptide increases resistance to venous return in ratsY W Chien, E D Frohlich, N C Trippodo
Pageof 37

Showing results (171-180 of 361) with videos related to

Sort By:
Pageof 37
American Journal of Nephrology|March 20, 2004
Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR modelXiaoyan Zhou, Hidehiko Ono, Yuko Ono, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|March 23, 2004
Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertensionDinko Susic, Jasmina Varagic, Jwari Ahn, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHRE Nunez, K Hosoya, D Susic, et al.
Hypertension (Dallas, Tex. : 1979)|August 1, 1996
Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAsD Susic, E Nuñez, E D Frohlich, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2003
Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamicsJasmina Varagic, Dinko Susic, Michel Slama, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1975
Hemodynamic effects of mebutamate in spontaneously hypertensive ratsJ M Pfeffer, M A Pfeffer, E D Frohlich
The American Journal of Cardiology|October 31, 1975
Systolic hypertension: nonhomogeneous diseasesP N Adamopoulos, S G Chrysanthakopoulis, E D Frohlich
Archives of Internal Medicine|July 1, 1984
Review of the overall experience of captopril in hypertensionE D Frohlich, R A Cooper, E J Lewis
Journal of Cardiovascular Pharmacology|January 1, 1985
Arterial compliance in essential hypertensionF H Messerli, E D Frohlich, H O Ventura
The American Journal of Physiology|May 1, 1987
Atrial natriuretic peptide increases resistance to venous return in ratsY W Chien, E D Frohlich, N C Trippodo
Pageof 37